The "Dialysis SARS-CoV-2 Screening Profile Test" is a specialized diagnostic assessment offered by DNA Labs UAE, tailored for patients undergoing dialysis. This test is designed to detect the presence of the SARS-CoV-2 virus, the causative agent of COVID-19, ensuring the safety and health of individuals who are often at a higher risk due to their compromised health status. Given the critical nature of maintaining a COVID-19-free environment in dialysis centers, this screening is pivotal for early detection and prevention of virus spread among a vulnerable population. The test is priced at 1400 AED, reflecting the comprehensive approach and the advanced technology utilized to achieve accurate and reliable results. Conducting such screenings is essential in these times to protect patients undergoing dialysis from potential COVID-19 complications, ensuring they receive their necessary treatments in the safest manner possible.
The Diphtheria-Pertussis-Tetanus (DPT) Antibody Panel IgG Test is a comprehensive immunological assessment designed to measure the levels of IgG antibodies against three critical bacterial infections: diphtheria, pertussis (whooping cough), and tetanus. This test is crucial for evaluating an individual's immune response to these infections, either through past exposure or vaccination. Conducted at DNA Labs UAE, a state-of-the-art facility known for its accurate and reliable diagnostic services, the test is priced at 1400 AED. It involves a simple blood draw, after which the sample is analyzed to determine the presence and quantity of IgG antibodies specific to each of the three pathogens. The results can help guide healthcare providers in making informed decisions regarding the need for booster vaccinations or further clinical management.
The Epstein-Barr Virus Antibody to Nuclear Antigen (EBNA) IgG Test is a specialized diagnostic procedure used to detect the presence of Immunoglobulin G (IgG) antibodies against the Epstein-Barr Virus (EBV) in the blood. EBV is a common herpesvirus that causes infectious mononucleosis and is associated with several types of cancers and autoimmune diseases. The presence of EBNA IgG antibodies typically indicates a past infection with EBV, as these antibodies usually develop several months after the initial infection and persist for life, providing long-term immunity.
This test is crucial for diagnosing and managing conditions related to EBV infections. It helps in differentiating between acute, past, and reactivated infections, which is essential for appropriate treatment and management. In the United Arab Emirates, the Epstein-Barr Virus Antibody to Nuclear Antigen EBNA IgG Test is available at DNA Labs UAE, a reputable laboratory known for its state-of-the-art facilities and precise diagnostic services. The test is priced at 1400 AED, reflecting the intricate technology and expertise required to accurately detect and measure the specific antibodies. Conducting this test at DNA Labs UAE ensures reliable results, aiding healthcare professionals in making informed decisions regarding patient care.
The FISH (Fluorescence In Situ Hybridization) - BCL6 3q27 Gene Rearrangement Test is a sophisticated diagnostic procedure utilized to identify rearrangements in the BCL6 gene located on chromosome 3q27. This specific gene rearrangement is often associated with various types of lymphomas, including diffuse large B-cell lymphoma (DLBCL), making this test a critical tool in the diagnosis and management of lymphoma patients. By employing fluorescent probes that bind to the BCL6 gene region, the FISH technique allows for the visualization of genetic abnormalities under a fluorescence microscope, providing precise and direct evidence of gene rearrangement.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test is meticulously conducted by skilled professionals who specialize in genetic diagnostics. The cost of the FISH - BCL6 3q27 Gene Rearrangement Test is set at 1400 AED, reflecting the advanced technology and expertise required to carry out this complex analysis. This test not only aids in the accurate diagnosis of lymphoma but also plays a significant role in determining the prognosis and guiding the treatment strategy for affected patients, thereby facilitating personalized medical care.
The FISH - NTRK 1 Gene Rearrangement Assay Test is a specialized diagnostic procedure aimed at detecting rearrangements in the NTRK1 gene. This test is crucial for identifying specific genetic alterations that may influence the behavior of certain cancers, thereby guiding tailored treatment options. The Fluorescence In Situ Hybridization (FISH) technique is utilized in this assay to visualize and map out the genetic changes in chromosomes, particularly focusing on the NTRK1 gene, which can play a significant role in tumor development and progression.
Performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities, the test offers a sophisticated level of diagnostic insight that can be pivotal for patients with cancers that may respond to targeted therapies. The cost of the test is set at 1400 AED, reflecting the intricate technology and expertise required to accurately identify NTRK1 gene rearrangements.
By opting for this test, patients and healthcare providers can make more informed decisions regarding treatment strategies, potentially leading to better outcomes through personalized medicine approaches.
The FISH (Fluorescence In Situ Hybridization) - NTRK 2 Gene Rearrangement Assay Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect rearrangements involving the NTRK2 gene. This test employs the FISH technique, a powerful molecular cytogenetic method that uses fluorescent probes to visualize and map the genetic material in an individual's cells, specifically targeting the NTRK2 gene to identify any structural changes.
NTRK2 gene rearrangements are critical to identify because they can play a significant role in the development and progression of various types of cancer. The presence of these rearrangements can influence treatment decisions, as certain targeted therapies are more effective in tumors with NTRK gene fusions.
The test is priced at 1400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE. By providing this service, DNA Labs UAE supports the precise diagnosis and personalized treatment planning for patients with tumors that may harbor NTRK gene rearrangements, contributing to more tailored and effective cancer care.
The FISH (Fluorescence In Situ Hybridization) - NTRK 3 Gene Rearrangement Assay Test is a sophisticated diagnostic procedure designed to identify rearrangements involving the NTRK3 gene. This gene plays a critical role in the development and function of the nervous system, and its rearrangements can lead to various types of cancer, including certain sarcomas, breast cancer, and thyroid cancer. The test utilizes fluorescent probes to visualize the presence or absence of specific genetic alterations directly within the chromosomes of cells extracted from a patient's tissue sample. This targeted approach allows for a high degree of specificity and sensitivity in detecting NTRK3 gene rearrangements.
Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, the test is available for a cost of 1400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. The FISH - NTRK 3 Gene Rearrangement Assay Test is crucial for patients suspected of having cancers that may involve NTRK3 gene alterations, as it can provide essential information for diagnosis, prognosis, and determining the most effective treatment strategy, including the possibility of targeted therapy.
The Gabapentin Test is a specialized diagnostic procedure aimed at detecting and measuring the levels of Gabapentin in the body. Gabapentin, a medication commonly prescribed for the management of neuropathic pain, seizures, and other conditions, requires careful monitoring to ensure therapeutic efficacy and avoid potential side effects. The test is particularly relevant for individuals undergoing treatment with Gabapentin, enabling healthcare providers to tailor dosages accurately and optimize treatment plans.
Conducted at DNA Labs UAE, a leading facility renowned for its advanced diagnostic services and adherence to international standards, the Gabapentin Test ensures precision and reliability. The test cost is set at 1400 AED, reflecting the sophisticated technology and expertise involved in the analysis. By choosing DNA Labs UAE for the Gabapentin Test, patients and healthcare providers can expect comprehensive support, from sample collection to detailed result interpretation, facilitating effective management of conditions requiring Gabapentin therapy.
The "HAINS Mycobacterium Tuberculosis First and Second Line Drug Resistance Profile Test" is a sophisticated diagnostic assessment offered by DNA Labs UAE, designed to detect resistance to both first and second-line anti-tuberculosis drugs. This test is crucial for tailoring the most effective treatment plans for individuals diagnosed with tuberculosis (TB), a contagious bacterial infection caused by Mycobacterium tuberculosis. By identifying specific genetic mutations associated with drug resistance, healthcare providers can make informed decisions on the most suitable medications, thus improving treatment outcomes and reducing the risk of further resistance development. The test is priced at 1400 AED, reflecting the advanced technology and expertise required to perform this comprehensive analysis. It represents a significant step forward in the fight against TB, particularly in cases where drug resistance poses a major treatment challenge.
The "Hair Transplant Panel B with COVID Antibodies Test" is a comprehensive diagnostic package offered by DNA Labs UAE, tailored for individuals considering hair transplantation while also assessing their COVID-19 antibody status. Priced at 1400 AED, this test panel is designed to ensure that candidates for hair transplant procedures are not only suitable for the surgery but are also evaluated for their immunity against COVID-19, which is crucial in the current pandemic scenario.
This dual-purpose test serves an essential role in pre-surgical planning by providing critical health information. The Hair Transplant Panel part of the test evaluates various factors that could affect the success of a hair transplant, such as hormonal levels and other markers important for hair growth and scalp health. Concurrently, the COVID Antibodies Test component measures the presence of antibodies against the SARS-CoV-2 virus, indicating past exposure to the virus and potentially offering insights into the patient's immune response.
Administered at the state-of-the-art facilities of DNA Labs UAE, this combined test ensures a holistic approach to patient care, addressing both the specific needs related to hair transplantation and the broader health considerations in light of the ongoing pandemic. The inclusion of the COVID-19 antibodies test adds an extra layer of safety for both patients and medical staff by identifying individuals who may have developed an immune response to the virus, thereby facilitating safer surgical environments and optimized patient care pathways.
